Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great news
It's frustrating..
Were are the TV ads, were is all of the hype that should be associated with a drug wit a RRR of 25%. Cant the big holders and Institutions make more money hyping the stock as opposed to what they are doing now.
Wish that we could see some direction from the company IMo..
It seems that Amarin may be sitting on their laurels right now, enjoying the fruits of Reduce-it
Every time I go into a pharmacy, the pharmacists are truly cognizant of Vascepa and its value..
Thoughts.. I'm just getting frustrated...with no patience....
Maybe once the public starts to complain followed by their docs too. Amarin needs to up their marketing imo
Thanks for your vote!
Best CEO of 2018
Josh Bilenker, Loxo Oncology
21%
Ludwig Hantson, Alexion Pharma
16%
Jeff Leiden, Vertex Pharma
24%
John Thero, Amarin
39%
Voting as of now
Exactly but if insurance company does not cover then it does not matter
If you get the md to write medically necessary on rx you bypass the attempted call to change
Cost!!!!!!!
utterly absurd
I think that’s it’s a noble quest for the board to spread the word about V but should we be coordinated with the parent company so that we do not step on any feet so to speak(stay away from the FDA). Since I feel that Amarin Being a small sized company might take longer to come out of the nebulous cloud that they find themselves in. I wish that they had a major Mkt company working for them
Did you get your v??
Excellent article need to get away from mo.
Should this endeavor be coordinated with Amarin...
I think that there needs to be a label change for the indicated TGL levels of High: 200 to 499 and above to garner more patients. My level was 313 and Medicare paid... My thoughts are that management is being overwhelmed by the reduce it study and results and that they need help... Thoughts
Stop the CoQ and see if the pain comes back and let us know...
I don't know why people have so much trouble getting it from their docs, Its not like your asking for opiates.... I asked mine to change me from fenofibric acid to V and no problem... Take the literature there with you
Amarin: A Poison Pill For The Miracle Pill
https://seekingalpha.com/article/4227015-amarin-poison-pill-miracle-pill
This can only be accomplished by mass marketing from Amarin!!
Since they have minimal sales reps then mass mail outs TV for patient participation, look at some of those cancer TV adds.... etc They need a major marketing company to enhance their position as a major company to be and not a small one..
Thoughts
The terms Penicillin and amoxicillin are generic terms whereby we would give you what ever brand we have in stock unless the doctor stated medically necessary for one specific brand. Now I would never change a V script to Lovaza because V is a different entity and not an approved orange book generic for it. So if the patient wanted the cheaper version the pharmacist should call the MD for approval, I retired 2 years ago and this should be still the correct MO.
Hope that this helps
It is not the pharmacist making the change but the Ins co. telling them to call the md's to change
So if the MD's put a Dispense as written(DAW1) connotation on the script that would help...
Thanks
Let them go after opiate fraud first, Ive worked in some mail order pharmacies in the past. You can not imagine the amt of Oxycodone that they send to patients.... thousands of dollars in street value..
17.99 and frozen....
What is the link to the new website..please
not official but they stated from teva and aurbindo that were manuf in India
this is what I fount on the recalls
in a recent notification on its website, the US Food and Drug Administration (FDA) said that the recall of drug substance Irbesartan was due to the presence of an impurity, N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution and industrial processes. NDEA has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC).
NDEA is used in the making of liquid rocket fuel and is a byproduct of fish processing as well as manufacturing of certain pesticides.
Preston
My wife takes losartin. First recall in August. Announced yesterday possible carcinogen
Excellent literature....
This is the link on Endocrinology advisor
https://www.endocrinologyadvisor.com/vascepa/drug/8148/
This is why we need help a BO or partnership to get the ship righted.....
Thanks
Remember ... today is the Fireside Chat.......
All this is well and good, But we have no idea of in which direction JT is going with the company.. If Vascepa is as great as published results, they now have a behemoth of a company to run and GIA would be like trying to run the government with 10 workers IMO
Yes, medicare pays for me. lobbyists are needed.
My thoughts exactly, at a minimum a partner
Great Yahoo story from yesterday
https://finance.yahoo.com/news/2-biotech-stocks-poised-big-190000459.html?.tsrc=daily_mail&uh_test=2_10
Thanks for your response. IMO a partnership would be the best of all worlds. Instant appreciation with 10 years of future appreciation of pps. Remember they can have their own generic too.
Great story. Can you send this post to Amrin to obtain their response. Since you are a MD and shareholder maybe a relalistic response might be forthcoming.
This is fantastic. Might take awhile to read.
Should be sent to all gp, internists, cardiologists
I do know the difference old age ....